Pathogenesis and pathology of different types of xenotransplant rejection

Current Opinion in Organ Transplantation

Volumn 9, Issue 2, 2004, Pages 163-169

  Cozzi, Emanuele ^a,b,c   Seveso, Michela ^b   Ancona, Ermanno ^a,b,c  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b CORIT   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Pathogenesis; Pathology; Primate; Rejection; Transgenic pig; Xenotransplantation

Indexed keywords

EID: 16344382844     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000127457.20432.03     Document Type: Review

References (91)

1. Asano M, Gundry SR, Izutani H, et al.: Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: effect of immunosuppressive regimen. J Thorac Cardiovasc Surg 2003, 125:60-70.
2. Zhong R, Tucker J, Zhang Z, et al.: The long-term survival of baboon-tomonkey kidney and liver xenografts. Xenotransplantation 2003, 10:398-409.
3. Pino-Chavez G: Differentiating acute humoral from acute cellular rejection histopathologically. Graft 2001, 4:60-63.
4. Schuurman HJ, Pino-Chavez G, Phillips MJ, et al.: Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAFtransgenic donors. Transplantation 2002, 73:1146-1151.
5. Platt JL, Fischel RJ, Matas AJ, et al.: Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991, 52:214-220.
6. Good AH, Cooper DK, Malcolm AJ, et al.: Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992, 24:559-562.
7. Sandrin MS, Vaughan HA, Dabkowski PL, et al.: Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A 1993, 90:11391-11395.
8. Cozzi E, White DJ: The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995, 1:964-966.
9. McCurry KR, Kooyman DL, Alvarado CG, et al.: Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995, 1:423-427.
10. Zaidi A, Schmoeckel M, Bhatti F, et al.: Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998, 65:1584-1590.
11. Chen RH, Naficy S, Logan JS, et al.: Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 1999, 6:194-200.
12. Mollnes TE, Fiane AE: Perspectives on complement in xenotransplantation. Mol Immunol 2003, 40:135-143.
13. Alwayn IP, Basker M, Buhler L, et al.: The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies. Xenotransplantation 1999, 6:157-168.
14. Yamada K, Yazawa K, Kamono C, et al.: An initial report of alpha-Gal deficient pig-to-baboon renal xenotransplantation: evidence for the benefit of cotransplanting vascularized donor thymic tissue. Xenotransplantation 2003, 10:480.
15. Sharma A, Naziruddin B, Cui C, et al.: Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen. Transplantation 2003, 75:430-436.
16. Peerschke EI, Ghebrehiwet B: Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. Immunobiology 1998, 199:239-249.
17. Platt JL, Lin SS, McGregor CG: Acute vascular rejection. Xenotransplantation 1998, 5:169-175.
18. Bach FH, Winkler H, Ferran C, et al.: Delayed xenograft rejection. Immunol Today 1996, 17:379-384.
19. Baldan N, Rigotti P, Calabrese F, et al.: Ureteral stenosis in HDAF pig-toprimate renal xenotransplantation: a phenomenon related to immunological events? Am J Transplant 2004, 4:475-481.
20. Goddard MJ, Dunning J, Horsley J, et al.: Histopathology of cardiac xenograft rejection in the pig-to-baboon model. J Heart Lung Transplant 2002, 21:474-484.
21. Shimizu A, Meehan SM, Kozlowski T, et al.: Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 2000, 80:815-830.
22. Holzknecht ZE, Kuypers KL, Plummer TB, et al.: Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ Res 2002, 91:1135-1141.
23. Buhler L, Xu Y, Li W, et al.: An investigation of the specificity of induced anti-pig antibodies in baboons. Xenotransplantation 2003, 10:88-93.
24. Bach FH: Xenotransplantation: problems and prospects. Annu Rev Med 1998, 49:301-310.
25. Bombeli T, Karsan A, Tait JF, et al.: Apoptotic vascular endothelial cells become procoagulant. Blood 1997, 89:2429-2442.
26. Bombeli T, Schwartz BR, Harlan JM: Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 1999, 93:3831-3838.
27. Saadi S, Takahashi T, Holzknecht RA, et al.: Pathways to acute humoral rejection. Am J Pathol 2004, 164:1073-1080.
28. Cozzi E, Bhatti F, Schmoeckel M, et al.: Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000, 70:15-21.
29. Loss M, Vangerow B, Schmidtko J, et al.: Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model. Xenotransplantation 2000, 7:186-196.
30. Katopodis AG, Warner RG, Duthaler RO, et al.: Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer. J Clin Invest 2002, 110:1869-1877.
31. Zhong R, Luo Y, Yang H, et al.: Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL. Transplantation 2003, 75:10-19.
32. Lin SS, Weidner BC, Byrne GW, et al.: The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998, 101:1745-1756.
33. Kuwaki K, Knosalla C, Dor FJ, et al.: Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant 2004, 4:363-372.
34. Dalmasso AP, He T, Benson BA: Human IgM xenoreactive natural antibodies can induce resistance of porcine endothelial cells to complement-mediated injury. Xenotransplantation 1996, 3:54-59.
35. Dorling A, Stocker C, Tsao T, et al.: In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and downregulation of VCAM expression induced by low concentrations of polyclonal human IgG anti-pig antibodies. Transplantation 1996, 62:1127-1136.
36. Ashton-Chess J, Roussel JC, Bernard P, et al.: The effect of immunoglobulin immunadsorptions on delayed xenograft rejection of human CD55 transgenic pig kidneys in baboons. Xenotransplantation 2003, 10:552-561.
37. Fecke W, Long J, Richards A, et al.: Protection of hDAF-transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex. Xenotransplantation 2002, 9:97-105.
38. Buhler L, Yamada K, Kitamura H, et al.: Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation 2001, 72:1743-1752.
39. Dorling A: Are anti-endothelial cell antibodies a pre-requisite for the acute vascular rejection of xenografts? Xenotransplantation 2003, 10:16-23.
40. Vangerow B, Hecker JM, Lorenz R, et al.: C1-Inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of h-DAF transgenic porcine kidneys. Xenotransplantation 2001, 8:266-272.
41. Robson SC, Cooper DK, d'Apice AJ: Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000, 7:166-176.
42. Ierino FL, Kozlowski T, Siegel JB, et al.: Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 1998, 66:1439-1450.
43. Cowan PJ, Aminian A, Barlow H, et al.: Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in nonimmunosuppressed baboons. Transplantation 2000, 69:2504-2515.
44. Cozzi E, Vial C, Ostlie D, et al.: Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts. Xenotransplantation 2003, 10:300-310.
45. Cozzi E, Cadrobbi R, Baldan N, et al.: Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation. Xenotransplantation 2003, 10:587-595.
46. Cozzi E, Simioni P, Boldrin M, et al.: Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation. Am J Transplant 2004, 4:335-345.
47. Schmoeckel M, Bhatti FN, Zaidi A, et al.: Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998, 65:1570-1577.
48. McGregor CG, Teotia SS, Schirmer JM, et al.: Cardiac xenotransplantation: 4 1/2 month survival in the laboratory. Xenotransplantation 2003, 10:480.
49. Gollackner B, Mueller NJ, Houser S, et al.: Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation. Transplantation 2003, 75:1841-1847.
50. Zhong R, Luo Y, Yang H, et al.: Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL. Transplantation 2003, 75:10-19.
51. Yamada K, Sachs DH, DerSimonian H: Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995, 155:5249-5256.
52. Dehoux JP, Nizet Y, de la Parra B, et al.: Cell-mediated cytotoxicity to porcine aortic endothelial cells is not dependent on galactosyl residues when baboon peripheral blood lymphocytes are previously primed with pig xenoantigens. Transplantation 2003, 76:1675-1680.
53. Rogers NJ, Jackson IM, Jordan WJ, et al.: Cross-species costimulation: relative contributions of CD80, CD86, and CD40. Transplantation 2003, 75:2068-2076.
54. Chan DV, Auchincloss H: Human anti-pig cell-mediated cytotoxicity in vitro involves non-T as well as T cell components. Xenotransplantation 1996;158-165.
55. Dawson JR, Vidal AC, Malyguine AM: Natural killer cell-endothelial cell interactions in xenotransplantation. Immunol Res 2000, 22:165-176.
56. Millan MT, Geczy C, Stuhlmeier KM, et al.: Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression. Transplantation 1997, 63:421-429.
57. Ehrnfelt C, Serrander L, Holgersson J: Porcine endothelium activated by antialpha- GAL antibody binding mediates increased human neutrophil adhesion under flow. Transplantation 2003, 76:1112-1119.
58. Sebille F, Dorling A, Lechler RI: The cellular rejection of xenografts-recent insights. Xenotransplantation 2003, 10:4-6.
59. Ashton-Chess J, Roussel JC, Manez R, et al.: Cellular participation in delayed xenograft rejection of hCD55 transgenic pig hearts by baboons. Xenotransplantation 2003, 10:446-453.
60. Bennet W, Sundberg B, Lundgren T, et al.: Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000, 69:711-719.
61. Goto M, Groth CG, Nilsson B, et al.: Intraportal pig islet xenotransplantation into athymic mice as an in vivo model for the study of the instant bloodmediated inflammatory reaction. Xenotransplantation 2004, 11:195-202.
62. Buhler L, Deng S, O'Neil J, et al.: Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation 2002, 9:3-13.
63. Cantarovich D, Blancho G, Potiron N, et al.: Rapid failure of pig islet transplantation in non human primates. Xenotransplantation 2002, 9:25-35.
64. Friedman T, Smith RN, Colvin RB, et al.: A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts. Diabetes 1999, 48:2340-2348.
65. Krook H, Hagberg A, Song Z, et al.: A distinct Th1 immune response precedes the described Th2 response in islet xenograft rejection. Diabetes 2002, 51:79-86.
66. Yi S, Feng X, Hawthorne WJ, et al.: CD4+ T cells initiate pancreatic islet xenograft rejection via an interferon-gamma-dependent recruitment of macrophages and natural killer cells. Transplantation 2002, 73:437-446.
67. Yi S, Hawthorne WJ, Lehnert AM, et al.: T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 2003, 170:2750-2758.
68. Zhan Y, Brady JL, Irawaty W, et al.: Activated macrophages require T cells for xenograft rejection under the kidney capsule. Immunol Cell Biol 2003, 81:451-458.
69. Solomon MF, Kuziel WA, Mann DA, et al.: The role of chemokines and their receptors in the rejection of pig islet tissue xenografts. Xenotransplantation 2003, 10:164-177.
70. Ehrnfelt C, Kumagai-Braesch M, Uzunel M, et al.: Adult porcine islets produce MCP-1 and recruit human monocytes in vitro. Xenotransplantation 2004, 11:184-194.
71. Schmidt P, Krook H, Maeda A, et al.: A new murine model of islet xenograft rejection: graft destruction is dependent on a major histocompatibilityspecific interaction between T-cells and macrophages. Diabetes 2003, 52:1111-1118.
72. Rayat GR, Johnson ZA, Beilke JN, et al.: The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Diabetes 2003, 52:1433-1440.
73. Zhan Y, Brady JL, Sutherland RM, et al.: Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing. J Immunol 2001, 167:6279-6285.
74. Dor FJ, Cheng J, Alt A, et al.: Galalpha1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus. Xenotransplantation 2004, 11:101-106.
75. Rayat GR, Rajotte RV, Hering BJ, et al.: In vitro and in vivo expression of Galalpha-(1,3)Gal on porcine islet cells is age dependent. J Endocrinol 2003, 177:127-135.
76. Bennet W, Bjorkland A, Sundberg B, et al.: A comparison of fetal and adult porcine islets with regard to Gal alpha (1,3)Gal expression and the role of human immunoglobulins and complement in islet cell cytotoxicity. Transplantation 2000, 69:1711-1717.
77. McKenzie IF, Koulmanda M, Mandel TE, et al.: Pig-to-human xenotransplantation: the expression of Gal alpha (1,3)Gal epitopes on pig islet cells. Xenotransplantation 1995, 2:1-7.
78. Schmidt P, Goto M, Le Mauff B, et al.: Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complementmediated cell lysis by human serum. Transplantation 2003, 75:697-702.
79. Bennet W, Bjorkland A, Sundberg B, et al.: Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs. Transplantation 2001, 72:312-319.
80. McKenzie IF, Li YQ, Xing PX, et al.: CD46 protects pig islets from antibody but not cell-mediated destruction in the mouse. Xenotransplantation 2003, 10:615-621.
81. Soderlund J, Wennberg L, Castanos-Velez E, et al.: Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 1999, 67:784-791.
82. Maeda A, Goto M, Zhang J, et al.: Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats. Transplantation 2003, 75:1409-1414.
83. Schuurman HJ, Wijkstrom M, Kirchhof N, et al.: Efficacy of porcine islet transplants in diabetic cynomolgus monkeys under chronic immunosuppression. Xenotransplantation 2003, 10:492.
84. Dufour JM, Rajotte RV, Korbutt GS, et al.: Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes. Immunol Invest 2003, 32:275-297.
85. Dufour JM, Rajotte RV, Kin T, et al.: Immunoprotection of rat islet xenografts by cotransplantation with Sertoli cells and a single injection of antilymphocyte serum. Transplantation 2003, 75:1594-1596.
86. Gores PF, Hayes DH, Copeland MJ, et al.: Long-term survival of intratesticular porcine islets in nonimmunosuppressed beagles. Transplantation 2003, 75:613-618.
87. Omer A, Keegan M, Czismadia E, et al.: Macrophage depletion improves survival of porcine neonatal pancreatic cell clusters contained in alginate macrocapsules transplanted into rats. Xenotransplantation 2003, 10:240-251.
88. Omer A, Duvivier-Kali VF, Trivedi N, et al.: Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 2003, 52:69-75.
89. Dwyer K, Robson SC, Nandurkar H, et al.: Survival of vascularised xenografts is prolonged using donor organs from transgenic mice expressing human CD39. Xenotransplantation 2003, 10:482.
90. Knosalla C, Cooper DK: Xenotransplantation and tolerance. Front Biosci 2002, 7:d1280-d1287.
91. Laumonier T, Mohacsi PJ, Matozan KM, et al.: Endothelial cell protection by dextran sulfate: a novel strategy to prevent acute vascular rejection in xenotransplantation. Am J Transplant 2004, 4:181-187.